Squarepoint’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Sell
410,282
-61,295
-13% -$285K ﹤0.01% 2239
2025
Q4
$2.59M Buy
471,577
+273,225
+138% +$1.33M ﹤0.01% 1875
2025
Q3
$649K Buy
198,352
+98,126
+98% +$278K ﹤0.01% 3018
2025
Q2
$232K Buy
+100,226
New +$218K ﹤0.01% 3884
2025
Q1
Sell
-211,842
Closed -$366K 5428
2024
Q4
$366K Buy
211,842
+108,719
+105% +$226K ﹤0.01% 4004
2024
Q3
$207K Buy
103,123
+22,868
+28% +$50.2K ﹤0.01% 3669
2024
Q2
$180K Sell
80,255
-133,691
-62% -$389K ﹤0.01% 3687
2024
Q1
$614K Buy
213,946
+150,469
+237% +$314K ﹤0.01% 2907
2023
Q4
$112K Buy
63,477
+34,909
+122% +$69.6K ﹤0.01% 3733
2023
Q3
$90.3K Sell
28,568
-52,066
-65% -$97.2K ﹤0.01% 3575
2023
Q2
$53.3K Buy
+80,634
New +$58.4K ﹤0.01% 3436
2022
Q1
Sell
-29,210
Closed -$340K 3538
2021
Q4
$340K Buy
+29,210
New +$441K ﹤0.01% 2380

Other funds holding TSHA